https://www.ampulmonary.com/asthma/article/22977979/reduce-asthma-inhaler-overuse-primary-care-quality-improvementPulmonaryen2026-11-05T18:01:43.000ZPrimary care initiative tackles asthma rescue inhaler overusehttps://img.ampulmonary.com/mindful/ascend/workspaces/default/uploads/2026/11/gettyimages-846570620-converted.zV7tdeoFwy.jpg?auto=format%252Ccompress&q=70https://www.ampulmonary.com/asthma/article/22977980/nebulized-hypertonic-saline-for-severe-asthmaPulmonaryen2026-11-05T17:49:40.000ZThe potential of nebulized hypertonic saline for severe asthmahttps://img.ampulmonary.com/mindful/ascend/workspaces/default/uploads/2026/11/gettyimages-2193206789.6v5xnvpLMu.jpg?auto=format%252Ccompress&q=70https://www.ampulmonary.com/copd/article/22977901/fda-grants-clearance-for-treprostinil-soft-mist-inhaler-clinical-trialPulmonaryen2026-11-04T20:56:05.000ZFDA grants clearance for treprostinil soft mist inhaler clinical trialhttps://img.ampulmonary.com/mindful/ascend/workspaces/default/uploads/2026/11/smi-clinical-trial.Syr20GD9Jo.jpg?auto=format%252Ccompress&q=70https://www.ampulmonary.com/copd/article/22977898/copd-treatment-falls-short-in-phase-2-proofofconcept-trialPulmonaryen2026-11-04T20:53:02.000ZCOPD treatment falls short in phase 2 proof-of-concept trialhttps://img.ampulmonary.com/mindful/ascend/workspaces/default/uploads/2026/11/proof-of-concept.XiIAUonFjD.jpg?auto=format%252Ccompress&q=70https://www.ampulmonary.com/copd/article/22977537/mepolizumab-reduces-systemic-corticosteroid-exposure-in-copd-patientsPulmonaryen2026-10-29T20:03:15.000ZMepolizumab reduces systemic corticosteroid exposure in COPD patientshttps://img.ampulmonary.com/mindful/ascend/workspaces/default/uploads/2026/10/cortecosteroid.KECVoEDsv8.jpg?auto=format%252Ccompress&q=70https://www.ampulmonary.com/copd/article/22977535/study-reveals-bmis-limitations-in-predicting-copd-riskPulmonaryen2026-10-29T20:00:42.000ZStudy reveals BMI's limitations in predicting COPD riskhttps://img.ampulmonary.com/mindful/ascend/workspaces/default/uploads/2026/10/bmi.9KP9O7xm7Y.jpg?auto=format%252Ccompress&q=70https://www.ampulmonary.com/pulmonary/article/22977532/hidden-immune-cell-unlocks-novel-treatment-approachPulmonaryen2026-10-29T19:35:10.000ZHidden immune cell unlocks novel treatment approachhttps://img.ampulmonary.com/mindful/ascend/workspaces/default/uploads/2026/10/wehi-cancr-cell-news-800x477.0mjheBbZtt.jpg?auto=format%252Ccompress&q=70A tissue sample taken from a long survivor patient with small cell lung cancer (SCLC), showing gamma delta T cells (red) infiltrating the SCLC cells (white). Other immune cells are shown in green.